Noninvasive Positive Pressure Ventilation for Difficult Weaning in Tracheotomy Patients
- Conditions
- Respiratory Failure
- Interventions
- Device: Noninvasive ventilation weaning
- Registration Number
- NCT01900990
- Lead Sponsor
- Chongqing Medical University
- Brief Summary
The investigators adopt Noninvasive Positive Pressure Ventilation for weaning in tracheotomy patients innovatively. The investigators randomly allocate the subjects into two groups. One group is weaned by traditional strategy. The other one is weaned by Noninvasive Positive Pressure Ventilation by plugging the tracheotomy tube and deflating the cuff.
- Detailed Description
The investigators adopt Noninvasive Positive Pressure Ventilation for weaning in tracheotomy patients innovatively .If patients'conditions met our defined criterions, the investigators randomly allocate two groups. One group adopts traditional weaning strategy, the other adopts Noninvasive Positive Pressure Ventilation. If patients' condition deteriorated in group two, the investigators turned them to invasive positive pressure ventilation, until patients adapted in a satisfactory condition, the investigators shift them into Noninvasive Positive Pressure Ventilation. The investigators will extubate the tracheotomy tube, if patients are received Noninvasive Positive Pressure Ventilation more than 24 to 48 hours. After extubation, the investigators try to wean Noninvasive Positive Pressure Ventilation. Successful wean is defined weaning mechanical ventilation more than 48 hours.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- age ≥ 18 years
- tracheotomy mechanical ventilation patients
- pregnancy
- respiratory and hemodynamic instability
- Recent oral,nasal,facial or cranial trauma or surgery
- contra-indications for nasal or facial mask (facial skin lesions,...)
- recent history of upper gastro-intestinal surgery
- recent history of myocardial infarction
- unconscious patients
- non cooperative patient
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Noninvasive ventilation weaning Noninvasive ventilation weaning Patients in this group were weaned by noninvasive ventilation
- Primary Outcome Measures
Name Time Method Main end-point defined as total duration of mechanical ventilation from admission to hospital to discharge from it or death The total duration of mechanical ventilation was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
- Secondary Outcome Measures
Name Time Method duration of invasive mechanical ventilation from admission to hospital to discharge from it or death The duration of invasive mechanical ventilation was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
duration of extubation tracheotomy tube from admission to hospital to discharge from it or death The duration of extubation tracheotomy tube was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
total duration of mechanical ventilation (invasive and non invasive) from admission to hospital to discharge from it or death The total duration of mechanical ventilation (invasive and non invasive) was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
successful weaning rate from admission to hospital to discharge from it or death The sucessful weaning rate was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
ICU length of stay from admission to hospital to discharge from it or death The ICU lentgh of stay was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
hospital length of stay from admission to hospital to discharge from it or death The hospital lentgh of stay was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.
Trial Locations
- Locations (1)
The First Affiliated Hospital ,Chongqing Medical Univercity
🇨🇳Chongqing, Chongqing, China